Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (9,085,268)	$ (1,980,570)	$ (11,964,663)	$ (2,513,975)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	56,739	1,024,444	99,295	1,038,322
Depreciation expense			46,394	42,768
Noncash lease expense			358	3,219
Gain on debt extinguishment				(160,588)
Change in fair value of convertible notes		76,738		76,738
Reverse recapitalization issuance costs in excess of gross proceeds	6,566,821		6,566,821
Change in fair value of derivative warrant liabilities	(1,454,440)		(1,454,440)
Changes in operating assets and liabilities:
Accounts receivable			(100,000)	109,868
Prepaid expenses and other current assets			(101,413)	(10,806)
Due from related parties			286	2,390
Accounts payable			983,634	(3,797)
Accrued expenses and other current liabilities			400,166	148,044
Security deposits			(11,000)
Deferred revenue				47,134
Net cash used in operating activities			(5,534,562)	(1,220,683)
Cash flows from investing activities:
Purchases of property and equipment			(3,453)
Net cash flows used in investing activities			(3,453)
Cash flows from financing activities:
Proceeds from issuance of preferred stock, net of offering costs				7,240,002
Net proceeds from Transaction and Maxim Private Placement			3,307,162
Proceeds from issuance of convertible notes				750,000
Proceeds from exercise of stock options			659,501
Net cash provided by financing activities			3,966,663	7,990,002
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total			(1,571,352)	6,769,319
Cash, cash equivalents and restricted cash at beginning of period			6,560,140	180,427
Cash, cash equivalents, and restricted cash at end of period	4,988,788	6,949,746	4,988,788	6,949,746
Supplemental information:
Cash and cash equivalents	4,938,788	6,924,746	4,938,788	6,924,746
Restricted cash	50,000	25,000	50,000	25,000
Total cash, cash equivalents, and restricted cash shown in statements of cash flows	$ 4,988,788	$ 6,949,746	4,988,788	6,949,746
Supplemental disclosure of noncash investing and financing activities:
Property and equipment additions included in accounts payable			25,154
Acquisition of right-of-use asset			162,634	404,625
Conversion of capital units into convertible preferred stock				10,681,040
Conversion of convertible preferred stock into common stock			20,857,453
Settlement of convertible notes for convertible preferred stock				$ 826,738
Issuance of common stock to settle stock issuance costs			3,443,750
Issuance of Series A preferred stock to settle stock issuance costs			910,000
Accretion on convertible preferred stock			201,168
Issuance of Series A preferred stock to settle underwriting fees payable assumed in Transaction			3,395,389
Derivative warrant liabilities assumed in Transaction			$ 2,286,379